Published April 2, 2020 | Version v1
Journal article Open

Novel Synthesis, spectral, characterization of 4,5-diphenyl-1-((tetrahydrofuran-2-yl)methyl)-2-(3,4,5-trichlorophenyl)-1H-imidazole and its applications of molecular docking, anticancer activity

Authors/Creators

  • 1. Department of Chemistry, Annamalai University, Annamalainagar - 608 002, India
  • 2. Department of Chemistry, St. Joseph University, Nagaland - 797 115, India
  • 3. Department of Chemistry, Pavai Arts and Science College for Women, Namkkal, Tamil Nadu - 637401, India

Description

In the present study of 4,5-diphenyl-1-((tetrahydrofuran-2-yl)methyl)-2-(3,4,5-trichlorophenyl)-1H-imidazole 1 was synthesized. The synthesized imidazole compound 1 has been characterized by FT-IR, 1H, 13C NMR and ESI-Mass spectral studies. Molecular docking is also performed in order to explain the over-expression of estrogen receptor in 70% of liver cancer. The imidazole scaffold is a privileged scaffold for exploration of anticancer agents. The objective of the present study is to evaluate the anticancer activity of imidazole 1 in human liver cancer cell lines HepG2.

Files

WNOFNS 30(2) (2020) 203-212.pdf

Files (1.0 MB)

Name Size Download all
md5:e6674c3926323dfee82c60d20dc88cab
1.0 MB Preview Download

Additional details

Identifiers

URL
https://www.worldnewsnaturalsciences.com/wp-content/uploads/2020/02/WNOFNS-302-2020-203-212.pdf

Related works

Cites
Journal article: https://www.worldnewsnaturalsciences.com/wp-content/uploads/2020/02/WNOFNS-302-2020-203-212.pdf (URL)

Software

Repository URL
https://www.worldnewsnaturalsciences.com/
Development Status
Active

References

  • [1] Y. Tian, M. Qin, X. Yang, X. Zhang, Y. Liu, X. Guo, and B. Chen. J. Tetrahedron 2019 V.75 no.19 pp. 2817-2823
  • [2] H.T. Gomez, E.H. Nunez, I.L. Rivera, J.G. Alverez, R.C. Rivera, R.M. Puc, and R.A. Ramo. Bio. Org. Med. Chem. Lett. 18 (2008) 3147-3151
  • [3] Y.F. Li, G.F. Wang, Y. Luo, W.G. Huang, W. Tang, C.L. Feng, L.P. Shi, Y.D. Ren, J.P. Zuo, and W. Lu, Eur. J. Med. Chem. 42 (2007) 1358-1364
  • [4] K.F. Ansari and C. Lal, Eur. J. Med. Chem. 44 (2009) 4028-4033
  • [5] J.C. Lee, J.T. Laydon, P.C. McDonnell, T.F. Gallagher, S. Kumar, D. Green, D. McNulty, M.J. Blumenthal, J.R. Keys, S.W.L. Vatter, J.E. Strickler, M.M. McLaughlin, I.R. Siemens, S.M. Fisher, G.P. Livi, J.R. White, J.L. Adams, and P.R. Young. Nature 372 (1994) 739-746
  • [6] S.M. Sondhi, R. Rani, J. Singh, P. Roy, S.K. Agrawal, and A.K. Saxena, Bioorganic & Medicinal Chemistry Letters, 02 Feb 2010, 20(7): 2306-2310
  • [7] K. Sztanke, K. Pasternak, A.Sidor - Wojtowicz, J. Truchlinska, and K. Jóźwiak. Bioorganic & Medicinal Chemistry, 07 Feb 2006, 14(11): 3635-3642
  • [8] P. Naik, P. Murumkar, R. Giridhar, and M.R. Yadav. J. Bioorg. Med. Chem. 18 (2010) 8418-8456
  • [9] M.M. Ramla, M.A. Omar, H. Tokuda, and H.I. El-Diwani. J. Bioorg. Med.Chem. 15 (2007) 6489-6496
  • [10] K.C.S. Achar, K.M. Hosamani, and H.R. Seetharamareddy. Eur. J. Med. Chem. 45 (2010) 2048–2054